Peloton Therapeutics, Inc. — Form D/A
Peloton Therapeutics, Inc. of DALLAS, TX, a company, filed a Form D amendment with the SEC on 2012-10-04. The offering totals $20.0M, of which $11.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-10-04
- Form: D/A
- Accession: 0001525145-12-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $20.0M
- Amount sold: $11.7M
- Remaining: $8.3M
- Investors: 4
- Date of first sale: 2011-06-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-162891
Issuer
- Name: Peloton Therapeutics, Inc.
- CIK: 0001525145
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 2330 INWOOD RD., DALLAS, TX, 75235
- Phone: 972-629-4100
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Michael Brown | Director | Malvern, PA |
| John Creecy | Director | San Antonio, TX |
| David Goeddel | Director | Agoura Hills, CA |
| Tim Kutzkey | Director | South San Francisco, CA |
| Brett RIngle | Director | Houston, TX |
| John Josey | Executive Officer | SOUTH SAN FRANCISCO, CA |
| Tim Kutzkey | Executive Officer | South San Francisco, CA |
Other filings by this issuer (1)
More